{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:59:55Z","timestamp":1790398795239,"version":"4.1.0"},"reference-count":12,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&T"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.5582\/ddt.2026.01040","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:11:08Z","timestamp":1787263868000},"page":"343-348","source":"Crossref","is-referenced-by-count":0,"title":["Disproportionality analysis of opioid-related urinary retention using the JADER database: Focus on the lack of signal for transdermal fentanyl"],"prefix":"10.5582","volume":"20","author":[{"given":"Yusuke","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Jichi Medical University Saitama Medical Center, Saitama, Japan."},{"name":"Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jichi Medical University Saitama Medical Center, Saitama, Japan."},{"name":"Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Sako","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoji","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Adult Cancer Pain. Version 1.2024. Available from: https:\/\/www.nccn.org\/guidelines\/category_1 (accessed March 23, 2026)"},{"key":"2","unstructured":"2. Tanaka Y. A case of urinary retention following oral morphine administration successfully treated by switching to a fentanyl patch. J Jpn Soc Pharm Oncol. 2025; 42:1-11. (in Japanese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H. Analyses of respiratory depression associated with opioids in cancer patients based on the Japanese Adverse Drug Event Report database. Biol Pharm Bull. 2019; 42:1185-1191.","DOI":"10.1248\/bpb.b19-00105"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Omoto T, Asaka J, Sakai T, Sato F, Goto N, Kudo K. Disproportionality analysis of safety signals for a wide variety of opioid-related adverse events in elderly patients using the Japanese Adverse Drug Event Report (JADER) database. Biol Pharm Bull. 2021; 44:627-634.","DOI":"10.1248\/bpb.b20-00904"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Uekusa S, Mogi K, Ota Y, Hanai Y, Kitagawa K, Yoshio T, Matsuo K. A pharmacovigilance study on psychotropic agent-induced urinary retention using the Japanese Adverse Drug Event Report database. Drugs Real World Outcomes. 2024; 11:691-700.","DOI":"10.1007\/s40801-024-00465-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13:e58-e68.","DOI":"10.1016\/S1470-2045(12)70040-2"},{"key":"7","unstructured":"7. Japanese Society for Palliative Medicine. Clinical guidelines for pharmacological management of cancer pain, 2020 edition. Tokyo: Kanehara & Co., Ltd.; 2020. p.59."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dobrek L. Lower urinary tract disorders as adverse drug reactions: A literature review. Pharmaceuticals (Basel). 2023; 16:1031.","DOI":"10.3390\/ph16071031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. El-Bindary EM, Bakry HH. Urodynamic changes following intrathecal administration of morphine and fentanyl in dogs. East Mediterr Health J. 2001; 7:189-196.","DOI":"10.26719\/2001.7.1-2.189"},{"key":"10","unstructured":"10. Bang EG, Kim SO, Hong JG. Comparison of intravenous patient-controlled analgesia with morphine and fentanyl in gastrectomy patients. Anesth Pain Med. 2008; 3:94-98."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004; 43:879-923.","DOI":"10.2165\/00003088-200443130-00004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cuvillon P, Alonso S, L'Hermite J, Reubrecht V, Zoric L, Vialles N, Luc Faillie J, Kouyoumdjian P, Boisson C, Raux M, Langeron O. Post-operative opioid-related adverse events with intravenous oxycodone compared to morphine: a randomized controlled trial. Acta Anaesthesiol Scand. 2021; 65:40-46.","DOI":"10.1111\/aas.13685"}],"container-title":["Drug Discoveries & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/4\/20_2026.01040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:29:59Z","timestamp":1790396999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/4\/20_2026.01040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2026.01040","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"2026.01040"}}